Evaluation of the genotoxicity of the phytoestrogen, coumestrol, in AHH-1 TK+/- human lymphoblastoid cells

被引:23
作者
Domon, OE
McGarrity, LJ
Bishop, M
Yoshioka, M
Chen, JJ
Morris, SM
机构
[1] US FDA, Div Genet & Reprod Toxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[2] US FDA, Div Biometry & Risk Assessment, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
关键词
coumestrol; human lymphoblastoid cells; TK mutations; loss-of-heterozygosity;
D O I
10.1016/S0027-5107(00)00170-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
Coumestrol, a phytoestrogen found in high levels in alfalfa and red clover, is of concern since endocrine disorders have been observed in farm animals exposed to high levels of phytoestrogens. Previous studies found that coumestrol was an effective inducer of DNA strand breaks, micronuclei, and mutations in the Hypoxanthine phosphoribosyl transferase (HPRT) gene of Chinese hamster ovary cells. In the experiments presented here, we extended the previous studies to examine the effect of coumestrol exposure on AHH-1 TK+/- human lymphoblastoid cells. Micronuclei were induced with the highest frequency occurring at day ? after exposure. Flow cytometric analysis of annexin V-FITC-7-aminoactinomycin D stained cells indicated that the primary pathway of cell death was by apoptosis. Mutations were induced in the Thymidine Kinase (TK) gene and were due primarily to the induction of clones with the slow-growth phenotype. Subsequent molecular analysis revealed the loss of exon 4 in the coumestrol-induced clones. indicative of loss-of heterozygosity and consistent with a proposed inhibition of topoisomerase-II activity as a mechanism of action for coumestrol. Taken together, these results suggest that coumestrol exhibits both mutagenic and clastogenic properties in cultured human lymphoblastoid cells. Published by Elsevier Science B.V.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 37 条
[1]
DIET AND BREAST-CANCER [J].
ADLERCREUTZ, H ;
MOUSAVI, Y ;
HOCKERSTEDT, K .
ACTA ONCOLOGICA, 1992, 31 (02) :175-181
[3]
Barrett J C, 1996, Prog Clin Biol Res, V394, P105
[4]
Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein [J].
Bertrand, P ;
Rouillard, D ;
Boulet, A ;
Levalois, C ;
Soussi, T ;
Lopez, BS .
ONCOGENE, 1997, 14 (09) :1117-1122
[5]
Interaction of p53 with the human Rad51 protein [J].
Buchhop, S ;
Gibson, MK ;
Wang, XW ;
Wagner, P ;
Sturzbecher, HW ;
Harris, CC .
NUCLEIC ACIDS RESEARCH, 1997, 25 (19) :3868-3874
[6]
ASSAY FOR GENE MUTATION IN A HUMAN LYMPHOBLAST LINE, AHH-1, COMPETENT FOR XENOBIOTIC METABOLISM [J].
CRESPI, CL ;
THILLY, WG .
MUTATION RESEARCH, 1984, 128 (02) :221-230
[7]
CRESPI CL, 1985, PROG MUTAT RES, V5, P197
[8]
MUTAGENICITY OF META-AMSA AND ORTHO-AMSA IN MAMMALIAN-CELLS DUE TO CLASTOGENIC MECHANISM - POSSIBLE ROLE OF TOPOISOMERASE [J].
DEMARINI, DM ;
DOERR, CL ;
MEYER, MK ;
BROCK, KH ;
HOZIER, J ;
MOORE, MM .
MUTAGENESIS, 1987, 2 (05) :349-355
[9]
SPECIFIC-LOCUS MUTATIONS INDUCED IN EUKARYOTES (ESPECIALLY MAMMALIAN-CELLS) BY RADIATION AND CHEMICALS - A PERSPECTIVE [J].
DEMARINI, DM ;
BROCKMAN, HE ;
DESERRES, FJ ;
EVANS, HH ;
STANKOWSKI, LF ;
HSIE, AW .
MUTATION RESEARCH, 1989, 220 (01) :11-29
[10]
EXTENSIVE LOSS OF HETEROZYGOSITY ACCOUNTS FOR DIFFERENTIAL MUTATION-RATE ON CHROMOSOME 17Q IN HUMAN LYMPHOBLASTS [J].
DOBO, KL ;
GIVER, CR ;
EASTMOND, DA ;
RUMBOS, HS ;
GROSOVSKY, AJ .
MUTAGENESIS, 1995, 10 (01) :53-58